Forbes covered the latest developments in the legalization of medical and recreation cannabis use in Mexico. Mexican President-elect Andres Manuel Lopez Obrador has expressed interest in legalization and last week, the country’s Supreme Court ruled that anti-cannabis laws were unconstitutional. However, Mexico isn’t the only country looking at decriminalizing cannabis and the US’s stance on cannabis is baring its entry into a lucrative market.

As more countries set forth to legalize the plant, the US is falling behind because the federal government still classifies cannabis in the same category as heroin, LSD and methamphetamine. Many US companies and investors have been locked out of the market due to this stance. As US companies are forced to sit on the sidelines, foreign companies are securing global distribution rights, creating supply chains and establishing subsidiaries that pass over the US, hurting its economy and stunting the growth of their domestic cannabis industry.


If and when the US decides to legalize cannabis on a federal level, US cannabis companies are going to be behind their well-funded foreign competitors. Until then, US cannabis companies will need to think of other ways to gain the opportunities and funding that they need to grow. They may want to take an interest in the strategies that foreign companies, such as Colombia-based Khiron Life Sciences Corp. (TSXV:KHRN) and sponsor cannabis conferences with the aim of educating legislators about the plant. Khiron was able to impress the former Mexican President Vicente Fox, who joined Khiron’s board shortly after the conference. Fox  will be an asset for the company as they move forward with their Latin American expansion plans.

To read the full article, click here.

Click here to connect with Khiron Life Sciences Corp. (TSXV:KHRN) for an Investor Presentation. 

Source: www.forbes.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Aurora Cannabis Inc. (NYSE: ACB) from February 13, 2020 through September 4, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Aurora Cannabis Inc. investors under the federal securities laws.

To join the class action, go here or call Vik Pawar, Esq. toll-free at 888-589-9804 or email info@pawarlawgroup.com for information on the class action.

Keep reading... Show less

The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less